Regorafenib + Panitumumab for Colorectal Cancers

ABSTRACT: Evaluate the safety of regorafenib and panitumumab

DISEASE(S): Colorectal Neoplasms,Kras And Nras Wild-type Colorectal Cancer

PROVIDER: 2171254 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR